We are always keen to work on your market access and pricing questions that are “off the beaten track”.
Because we are small and agile, some of our Global clients have found us an ideal partner to investigate some less obvious market access questions for them. These can range from a deep dive into a specific ‘off the beaten track’ country, the understanding of more tactical aspects in regional systems, to mapping out the reimbursement opportunities for new technologies, devices, diagnostics and so forth.
When we are asked to conduct strategic research on market access, we are typically asked to cover EU5 and USA.
read more
In recent years, the Spanish drug agency, AEMPS, and the “Interministerial Commission on Prices of Medicines and Health Products” have undergone a major reform.
Read more...
read more
